NCT06953024View on ClinicalTrials.gov

Validation of Self Testing Using the INSTI Multiplex HIV1/2 Syphilis Antibody Test

NANot yet recruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions

HivSyphilis

Interventions

DIAGNOSTIC_TEST

INSTI HIV/syphilis Point of Care Self-Test Administration

The INSTI Human Immunodeficiency Virus (HIV)/syphilis POCT is a rapid, single-use, flow-through immunoassay that is Health Canada-approved as a screening test for detecting antibodies to HIV1/2 and syphilis using a fingerstick blood sample.

All Listed Sponsors

lead

Nova Scotia Health Authority

OTHER

NCT06953024 - Validation of Self Testing Using the INSTI Multiplex HIV1/2 Syphilis Antibody Test | Biotech Hunter | Biotech Hunter